BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Life Raft Group - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://liferaftgroup.org
X-WR-CALDESC:Events for The Life Raft Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250619T190000
DTEND;TZID=America/New_York:20250619T190000
DTSTAMP:20260406T165019
CREATED:20250513T131917Z
LAST-MODIFIED:20250515T204708Z
UID:10000823-1750359600-1750359600@liferaftgroup.org
SUMMARY:Updates from ASCO 2025
DESCRIPTION:ASCO (American Society of Clinical Oncology) is an important conference in the oncology community where new scientific research updates are shared. The Life Raft Group is excited to partner with Herbert Loong\, who will summarize abstracts and presentations that were presented during this conference that are relevant to the GIST patient community. Join us June 19th at 7pm for this virtual presentation. A Q&A session will follow the presentation. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to srothschild@liferaftgroup.org. \nREGISTERAbout Our Presenter\n \nDr. Herbert Loong \nThe Chinese University of Hong Kong \nDr. Herbert H. Loong holds conjoint appointments of Clinical Associate Professor in the Department of Clinical Oncology and Deputy Medical Director of the Phase 1 Clinical Trials Centre of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team. \nDr. Loong has served or continues to serve in various capacities in various professional international oncology bodies\, including the International Affairs Committee and the Asia-Pacific Regional Council of ASCO\, the Membership\, Education and Communications Committees of the IASLC. He has been elected as a Board Member of the Connective Tissue Oncology Society (CTOS) for 2022-2024. He is also a founding executive committee member of the newly formed Asia Pacific Oncology Drug Development Network (APODDC). He is also a Board Member in the specialty of Medical Oncology in the Hong Kong College of Physicians. In his appointment as a Registration Committee member of Pharmacy and Poisons Board of Hong Kong\, he helps oversee the registration of medicinal products and clinical trials in the territory. \nThank You to Our Sponsors!
URL:https://liferaftgroup.org/event/updates-asco-2025/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250630T120000
DTEND;TZID=America/New_York:20250630T120000
DTSTAMP:20260406T165019
CREATED:20250516T163719Z
LAST-MODIFIED:20250623T151652Z
UID:10000825-1751284800-1751284800@liferaftgroup.org
SUMMARY:Navigating Financial Support & Medicare Changes
DESCRIPTION:The Life Raft Group is partnering with Jennifer Noonan of Accessia Health to present “Navigating Financial Support & Medicare Changes: What Patients Need to Know in 2025” to our patient and caregiver community on June 30th at 12PM ET. During this virtual presentation\, Ms. Noonan will cover key updates including the Medicare Prescription Payment Plan (M3P)\, cost-sharing “smoothing\,” and how charitable financial assistance programs can support individuals navigating high out-of-pocket costs. Learn what these changes mean for patients and caregivers — and how to prepare for what’s ahead. A Q&A segment will follow Ms. Noonan’s presentation. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to rpauley@liferaftgroup.org. \nREGISTERAbout Our Presenter\n \nJennifer Noonan\nAccessia Heath \nJennifer Noonan\, Vice President of Clinical Strategy & Patient Engagement at Accessia Health\, is a dedicated healthcare professional with 25+ years of clinical nursing experience. Her vast clinical management background spans diverse healthcare settings\, showcasing her expertise in program design and service delivery under rigorous regulations. Her career began in emergency medicine in Louisville\, KY\, where she spent 17 years in leadership roles and contributing to EMR clinical development and implementation. Transitioning into hospice and palliative care in 2014\, Jennifer excelled in leadership positions for both adult and pediatric patients. A resolute academic\, Jennifer holds degrees from Kentucky State University and Western Governors University. She was appointed to the National Association of Specialty Pharmacy’s Board of Directors in September 2023. Beyond work\, she is a family-oriented martial arts enthusiast\, hiker\, and avid traveler. \nThank You to Our Sponsors!\n 
URL:https://liferaftgroup.org/event/navigating-financial-support/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Rebecca Pauley":MAILTO:rpauley@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250711T140000
DTEND;TZID=America/New_York:20250711T140000
DTSTAMP:20260406T165019
CREATED:20250513T130002Z
LAST-MODIFIED:20250710T185244Z
UID:10000824-1752242400-1752242400@liferaftgroup.org
SUMMARY:GIST Awareness Day Fireside Chat
DESCRIPTION:July 13th\, GIST Awareness Day\, is a time when GIST experts\, patients\, and caregivers come together to educate the public about this disease and advocate for finding a cure.  The Life Raft Group invites GIST patients and caregivers to celebrate GIST Awareness Day with us on July 11th at 2PM ET. During this virtual event\, esteemed GIST experts Dr. Sicklick of UCSD and Dr. Blakely and Dr. John Glod of the NIH will answer patient and caregiver questions in an informal chat. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to srothschild@liferaftgroup.org. \nREGISTERAbout Our Presenters\n \nDr. Jason Sicklick\nUCSD\, Moores Cancer Center \nJason Sicklick\, MD\, is an internationally recognized surgical oncologist who specializes in treating gastrointestinal stromal tumors (GIST)\, abdominal/retroperitoneal sarcomas\, and liver tumors.He leader of the Sarcoma Disease Team and Co-leader of the Structural and Function Genomics Program at UC San Diego Health’s Moores Cancer Center. He is also a member of the National Comprehensive Cancer Network Soft-Tissue Sarcoma Committee and GIST Subcommittee\, which develops best practices for treating these rare and often challenging-to-treat cancers. \n \nDr. Andrew Blakely\nNational Cancer Institute (NCI) \nDr. Blakely completed a Bachelor of Science in Biomedical Engineering followed by medical school at Drexel University. He went on to general surgery residency at Brown University. During residency\, he spent two years of dedicated research time at the Center for Biomedical Engineering developing a device for tissue engineering applications. Dr. Blakely then completed his fellowship in Complex General Surgical Oncology at City of Hope National Medical Center. Dr. Blakely is currently a surgical oncologist specializing in peritoneal surface malignancies and soft tissue sarcomas. One of the primary focuses of his research includes improving surgical treatment and ex vivo tumor modeling of gastrointestinal stromal tumors. \n \nDr. John Glod\nNational Cancer Institute (NCI) \nDr. Glod obtained his M.D. and Ph.D. from the University of Colorado in Denver and trained in pediatrics and pediatric oncology at Cincinnati Children’s Hospital\, Johns Hopkins Hospital\, and the Pediatric Oncology Branch of the NCI.  Dr. Glod currently serves as the Clinical Director of the Pediatric Oncology Branch in the Center for Cancer Research at National Cancer Institute. Dr. Glod’s research interests are focused on early stage clinical trials for pediatric patients and rare pediatric solid tumors including multiple endocrine neoplasia-related medullary thyroid cancer\, SDH-deficient gastrointestinal stromal tumor\, and tumors of the central nervous system. \nThank You to Our Sponsors!\n 
URL:https://liferaftgroup.org/event/gad-fireside-chat/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250714T120000
DTEND;TZID=America/New_York:20250714T120000
DTSTAMP:20260406T165019
CREATED:20250318T174657Z
LAST-MODIFIED:20250711T200848Z
UID:10000815-1752494400-1752494400@liferaftgroup.org
SUMMARY:Día del aprendizaje sobre GIST en español
DESCRIPTION:RESERVE LA FECHA – 14 de Julio\n \nPronto compartiremos la agenda. \n¡Reserve la fecha para el primer GIST Day of Learning en español!  \nEl día del aprendizaje sobre Los Tumores del Estroma Gastrointestinal (GIST) es un evento gratuito diseñado para pacientes y cuidadores\, donde pueden informarse sobre este cáncer poco común\, encontrar apoyo y fortalecer su conocimiento para afrontar su camino contra el GIST. \nREGISTRATELink Agenda PDF\n \n¿Qué es un GDOL? \nUn GDOL es un GIST Day of Learning (Día de Aprendizaje sobre GIST). Este es un evento gratuito de un día diseñado para ayudar a pacientes y cuidadores a aprender más sobre este cáncer raro\, encontrar apoyo y ampliar sus conocimientos para navegar su camino en el tratamiento del cáncer. \nThe Life Raft Group está comprometido con mejorar la supervivencia y calidad de vida de las personas que viven con Tumor del Estroma Gastrointestinal (GIST) y otras enfermedades raras\, a través de la investigación impulsada por los pacientes\, la educación\, el empoderamiento y esfuerzos de defensa a nivel global. Nuestra visión es impulsar un futuro basado en datos\, guiando nuestro camino hacia la cura de enfermedades raras. \nSi tiene alguna pregunta\, comuníquese con Brian Morello en bmorello@liferaftgroup.org. \nGracias a Nuestros Patrocinadores!
URL:https://liferaftgroup.org/event/dia-del-aprendizaje-sobre-gist-en-espanol/
CATEGORIES:Education,Events
ORGANIZER;CN="Rebecca Pauley":MAILTO:rpauley@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250812T120000
DTEND;TZID=America/New_York:20250812T120000
DTSTAMP:20260406T165019
CREATED:20250707T163827Z
LAST-MODIFIED:20250707T193754Z
UID:10000828-1755000000-1755000000@liferaftgroup.org
SUMMARY:Making Cents of Caregiving
DESCRIPTION:The Life Raft Group is partnering with Al Berg of the AARP NJ Speakers Bureau to present “Making Cents of Caregiving” on August 12\, at 12PM ET. In this informative and educational session\, you will be introduced to essential information caregivers need to more easily manage the financial complexities of caregiving. Over the course of the presentation\, you will learn how to incorporate financial tips and resources into your caregiving. By the end of the session\, we hope you have the confidence to make your own financial plans for your loved one’s care and well-being. A question and answer session will follow the presentation. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to rpauley@liferaftgroup.org. \nREGISTERAbout Our Presenters\n \nAl Berg\nAARP NJ Speakers Bureau \nAl Berg is a volunteer with the AARP NJ Speakers Bureau\, giving presentations on a variety of topics of interest to older Americans.  During the day\, Al heads up cybersecurity for a major entertainment company. When he is not fighting off hackers\, he is an EMT with the Weehawken Volunteer First Aid Squad and lives in Weehawken with his wife and a very spoiled cat. \nThank You to Our Sponsors!\n 
URL:https://liferaftgroup.org/event/making-cents-of-caregiving/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Rebecca Pauley":MAILTO:rpauley@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250913T080000
DTEND;TZID=America/New_York:20250913T080000
DTSTAMP:20260406T165019
CREATED:20250310T193818Z
LAST-MODIFIED:20250905T005807Z
UID:10000813-1757750400-1757750400@liferaftgroup.org
SUMMARY:GDOL Los Angeles
DESCRIPTION:GDOL Los Angeles will take place in-person on September 13th at UCLA Health. \nREGISTERClick for PDF Agenda\n\n \nWhat is a GDOL? \nA GDOL is a GIST Day of Learning. This is a free one day event to help patients and caregivers learn more about this rare cancer\, find support\, and enhance their knowledge base to help them navigate their cancer journey. \nThe Life Raft Group is committed to enhancing the survival and quality of life for people living with Gastrointestinal Stromal Tumor (GIST)\, and other rare diseases\, through patient-powered research\, education and empowerment\, and global advocacy efforts. Our vision is to empower a future fueled by data\, guiding our journey toward cures for rare diseases. \nIf you have any questions\, please contact Brian Morello at bmorello@liferaftgroup.org
URL:https://liferaftgroup.org/event/gdol-los-angeles/
CATEGORIES:Education,Events
ORGANIZER;CN="Brian Morello":MAILTO:bmorello@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250927T080000
DTEND;TZID=America/New_York:20250927T080000
DTSTAMP:20260406T165019
CREATED:20250310T203711Z
LAST-MODIFIED:20250925T145704Z
UID:10000814-1758960000-1758960000@liferaftgroup.org
SUMMARY:GDOL Boston
DESCRIPTION:GDOL Boston will take place in-person on September 27th at the Dana-Farber Cancer Institute. \nREGISTERClick for PDF Agenda\n \nWhat is a GDOL? \nA GDOL is a GIST Day of Learning. This is a free one day event to help patients and caregivers learn more about this rare cancer\, find support\, and enhance their knowledge base to help them navigate their cancer journey. \nThe Life Raft Group is committed to enhancing the survival and quality of life for people living with Gastrointestinal Stromal Tumor (GIST)\, and other rare diseases\, through patient-powered research\, education and empowerment\, and global advocacy efforts. Our vision is to empower a future fueled by data\, guiding our journey toward cures for rare diseases. \nIf you have any questions\, please contact Brian Morello at bmorello@liferaftgroup.org
URL:https://liferaftgroup.org/event/gdol-boston/
CATEGORIES:Education,Events
ORGANIZER;CN="Brian Morello":MAILTO:bmorello@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251004T100000
DTEND;TZID=America/New_York:20251004T160000
DTSTAMP:20260406T165019
CREATED:20250812T163703Z
LAST-MODIFIED:20250812T163703Z
UID:10000919-1759572000-1759593600@liferaftgroup.org
SUMMARY:Montreal GIST Day of Learning/Annual General Meeting
DESCRIPTION:GIST Sarcoma LRG Canada is hosting a GIST Day of Learning/GDOL/Annual Meeting on October 4 in Montreal for patients and caregivers. Refreshments and lunch provided.\nMORE Info/register
URL:https://liferaftgroup.org/event/montreal-gist-day-of-learning-annual-general-meeting/
CATEGORIES:Education,Events
ORGANIZER;CN="GIST Sarcoma Life Raft Group Canada":MAILTO:yvonne.nunnaro@liferaftgroup.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251110T140000
DTEND;TZID=America/New_York:20251110T140000
DTSTAMP:20260406T165019
CREATED:20250721T171140Z
LAST-MODIFIED:20251015T155959Z
UID:10000846-1762783200-1762783200@liferaftgroup.org
SUMMARY:ctDNA and the INSIGHT Study
DESCRIPTION:REGISTERThe Life Raft Group is partnering with Deciphera Pharmaceuticals and Dr. Jonathan Trent of the Sylvester Comprehensive Cancer Center to present “ctDNA and the INSIGHT Study” on November 10th at 2PM ET. During this virtual presentation\, Dr. Trent will explain how ctDNA works as a non-invasive method to monitor mutations and disease progression\, and how it may help personalize treatment strategies for GIST patients. \nDenisse Evans\, Sr. Director of Data Management & Research for the LRG\, will present the results and analysis of the LRG’s recent patient survey: Understanding Mutational and ctDNA Testing for patients in the U.S. She will highlight how patients currently access and understand testing\, key barriers to uptake\, and what these findings reveal about the real-world experiences of the GIST community. Denisse will also discuss how these insights can help shape future education\, advocacy\, and research efforts to ensure patients have the tools they need to make informed decisions about their care. \nA question-and-answer session will follow the presentation. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to rpauley@liferaftgroup.org. \nAbout Our Presenters\n \nDr. Jonathan Trent\nSylvester Comprehensive Cancer Center \nJonathan Trent\, M.D.\, Ph.D. is a board‑certified oncologist\, professor of medicine\, and Associate Director for Clinical Research at the Sylvester Comprehensive Cancer Center\, University of Miami Health System. He serves as the Director of the Bone and Soft-Tissue Sarcoma Group and leads the Sarcoma Medical Oncology program\, with a focus on gastrointestinal stromal tumor (GIST)\, chondrosarcoma\, synovial sarcoma\, and other rare sarcomas. \nDenisse Evans\, MS\nSenior Director\, Data Mgmt. & Research \nMs. Evans has a wealth of experience in clinical evaluation projects including development of protocols\, case report forms\, informed consent\, surveys\, tissue repositories\, and study initiation She is proficient in data management\, preparing research for publication\, drug development\, clinical trial protocols\, onco-pathological/genetical dissemination\, and formulating research premises. As the Senior Director of Data Management & Research\, Denisse is the principal investigator for study protocol design and strategy of Patient Reported Outcomes (PRO). She has expertise in the analysis\, reporting\, and dissemination of PRO data and present scientific work. \nShe leads a dedicated staff in both patient support and in the identification of data trends that may lead to actionable information that will help patients coping with Gastrointestinal Stromal Tumor. In addition\, she takes the lead in collaborative research initiatives\, including maintaining relationships with potential partners\, contributing ongoing data\, and supporting hypothesis generation with the goal of increasing patient survival and advancing GIST research. \nDenisse holds a Bachelor of Science degree in Biology from Rowan University\, and a Master of Science Degree in Biomedical Science from Fairleigh Dickinson University. \nThank You to Our Sponsor!
URL:https://liferaftgroup.org/event/ctdna-and-the-insight-study/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Rebecca Pauley":MAILTO:rpauley@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251203T120000
DTEND;TZID=America/New_York:20251203T120000
DTSTAMP:20260406T165019
CREATED:20251105T160426Z
LAST-MODIFIED:20251105T160426Z
UID:10000922-1764763200-1764763200@liferaftgroup.org
SUMMARY:Updates from CTOS 2025
DESCRIPTION:REGISTERThe CTOS Annual Meeting is the yearly conference of the Connective Tissue Oncology Society\, where global sarcoma experts share new research and clinical insights. The Life Raft Group is partnering with Dr. Pawel Sobczuk of Vall d’Hebron Institute of Oncology to present “GIST Updates from CTOS 2025” on December 3rd at 12 PM ET. During this virtual session\, Dr. Sobczuk will highlight key GIST-relevant findings presented at CTOS\, followed by a Q&A with attendees. \nAbout Our Presenter\n \nDr. Pawel Sobczuk\nVall d’Hebron Institute of Oncology\, Barcelona\, Spain \nPawel Sobczuk is a Polish medical oncologist and clinician-scientist with expertise in sarcoma and skin tumours. He currently works as a postdoctoral fellow at the Sarcoma Translational Research Group at Vall d’Hebron Institute of Oncology in Barcelona\, Spain. He is a Board member of the Polish Society of Clinical Oncology. Dr. Sobczuk is a member of the ESMO Young Oncologists Committee and ESMO Communication Committee.\nDr. Sobczuk completed his medical degree at the Medical University of Warsaw. Following his medical studies\, he undertook a residency in Medical Oncology at Maria-Sklodowska Curie National Research Institute of Oncology in Warsaw\, where he also completed his PhD in medical sciences in 2023. He has completed a scientific fellowship at the Memorial Sloan Kettering Cancer Center in New York.\nHis research primarily focuses on translational studies in sarcoma\, with a primary interest in response to immunotherapy and novel mechanisms of resistance to kinase inhibitors in GIST. Dr Sobczuk is a co-principal investigator of the EFTISARC-NEO clinical trial evaluating a novel immunotherapy combination in the neoadjuvant treatment of patients with soft tissue sarcoma. He has published more than 40 peer-reviewed articles in indexed journals and presented results in numerous international meetings. He serves as a member of the editorial board of renewed journals such as JCO Precision Oncology and Cancer Control. \nThank You to Our Sponsors!
URL:https://liferaftgroup.org/event/updates-from-ctos-2025/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Rebecca Pauley":MAILTO:rpauley@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260225T120000
DTEND;TZID=America/New_York:20260225T120000
DTSTAMP:20260406T165019
CREATED:20260114T141731Z
LAST-MODIFIED:20260220T204707Z
UID:10001086-1772020800-1772020800@liferaftgroup.org
SUMMARY:Histotripsy Demystified
DESCRIPTION:REGISTERThe Life Raft Group is proud to present “Histotripsy Demystified: Truths and Misconceptions Explained\,” taking place on February 25\, 2026\, from 12:00–1:30 PM ET. \nThis webinar features an expert panel moderated by Dr. Elizabeth Lilley of Brigham and Women’s Hospital with Dr. Hop Tran Cao (MD Anderson Cancer Center)\, Dr. Suzanne George (Dana-Farber Cancer Institute)\, Dr. Christina Angeles (University of Michigan)\, Dr. Alicia Gingrich (University of Nevada/Renown Health System) and Dr. Jiping Wang and Dr. Chandrajit Raut (Brigham and Women’s Hospital/Harvard Medical School). \nThis virtual discussion is open to patient and caregivers of ALL sarcoma types. \nHistotripsy is a noninvasive treatment that uses focused ultrasound to mechanically destroy targeted tissue without surgery\, incisions\, or radiation. The procedure has only recently moved into human clinical trials and clinical use\, with the first FDA clearance for treating liver tumors granted in October 2023 and broader study and adoption continuing through the mid-2020s. \nThis virtual panel discussion will bring together experts from multiple institutions to share diverse perspectives on histotripsy\, including how the technology works\, where the science currently stands\, and common myths and misconceptions. Because histotripsy is being explored across multiple tumor types\, the discussion will be relevant and beneficial to all sarcoma patients seeking to better understand emerging treatment approaches and their potential future role in care. A moderated Q&A segment will follow the discussion. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. \nAbout Our Presenters:\n \nModerator: Dr. Elizabeth Lilley\nBrigham and Women’s Hospital \nDr. Elizabeth Lilley is a surgical oncologist at Brigham and Women’s Hospital specializing in the management of soft tissue sarcomas\, including gastrointestinal stromal tumors (GIST)\, with a special focus on robotic and minimally invasive surgical techniques. Dr. Lilley is triple board certified in surgical oncology\, general surgery\, and palliative medicine. Her research focuses on improving the quality of surgical care for patients with metastatic and recurrent cancers by improving communication surrounding the goals and outcomes of surgery. \nDr. Lilley earned a bachelor’s degree in neuroscience from Lafayette College\, a master’s of public health from Columbia University\, and a medical degree from Rutgers. She completed general surgery residency at Brigham and Women’s Hospital\, followed by the Harvard Interdisciplinary Palliative Care Fellowship. Upon completing fellowship training in Complex General Surgical Oncology at MD Anderson Cancer Center\, she joined the faculty at Brigham and Women’s Hospital and Harvard Medical School\, where she now leads a health services research program centered on the intersection of surgical oncology and palliative care. Her combined expertise in both sarcoma surgery and palliative medicine uniquely positions her to improve the person-centered care of patients with advanced sarcomas. \n \nDr. Christina Angeles\nUniversity of Michigan \nDr. Angeles is an Associate Professor with Tenure of Surgery\, Associate Professor of Dermatology\, and Faculty Member in the Cancer Biology PhD Program at the University of Michigan in the Division of Surgical Oncology. She earned her medical degree at Tufts University School of Medicine. She completed general surgery residency at New York Presbyterian-Weill Cornell Medical Center. While in residency she completed a two-year basic/translational science Surgical Oncology Research Fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) focusing on the molecular biology and novel therapeutics for sarcoma. After residency\, Dr. Angeles returned to MSKCC and completed a clinical Complex Surgical Oncology Fellowship. Dr. Angeles is board-certified in both General Surgery and Complex General Surgical Oncology. She is the Director of the Regional Cancer Therapies Clinic at University of Michigan/Rogel Cancer Center. \nDr. Angeles is a nationally recognized surgeon-scientist dedicated to advancing cancer care through innovative research and compassionate patient care. As the lead investigator for multiple clinical trials at the Rogel Cancer Center\, she is at the forefront of developing new treatments for melanoma and sarcoma. Her laboratory studies the immune system’s role in fighting cancer\, with a special focus on how resident memory T cells can help create long-lasting protection against tumors. By combining basic science and translational research\, Dr. Angeles and her team are working to transform discoveries in the lab into effective new therapies for patients. Dr. Angeles’s research has been supported by the American Cancer Society\, the Melanoma Research Alliance\, the Society of Surgical Oncology\, and the National Institutes of Health’s National Cancer Institute (NCI-NIH). \n \nDr. Suzanne George\nDana-Farber Cancer Institute \nSuzanne George\, MD is the Division Chief of the Sarcoma Center at Dana-Farber Cancer Institute where leads a team focused on research and clinical care of patients with sarcomas and GIST. She has an extensive research experience in clinical trials and drug development and cares for patient from across New England\, the US and internationally. \n \nDr. Alicia Gingrich\nUniversity of Nevada/ Renown Medical Group \nDr. Gingrich is a surgical oncologist at the University of Nevada\, Reno. She attended medical school at the University of Kansas prior to completing general surgery residency at the University of California\, Davis. She trained at MD Anderson for her complex general surgical oncology fellowship. Dr. Gingrich’s clinical practice focuses on soft tissue sarcoma and GIST as well as hepatobiliary tumors. The University of Nevada\, Reno/Renown were one of the early adopters of Histotripsy and have been performing this procedure for 2 years. She utilizes Histotripsy for select patients with liver tumors. \n \nDr. Chandrajit P. Raut\nChief\, Division of Surgical Oncology\, Mass General Brigham \nDr. Raut is a dedicated surgical oncologist who specializes in the multidisciplinary care of patients with soft tissue sarcoma.  He is a prolific researcher who has received federal funding to investigate sarcoma tumor genetics and identify strategies at reducing sarcoma recurrence rates.  Additionally\, he has served as co-PI or institutional PI on several US and international phase 2 or phase 3 clinical trials evaluating neoadjuvant or adjuvant therapies in various sarcomas. \nDr. Raut is a graduate of Stanford University\, University of Oxford\, and Harvard Medical School.  He completed his general surgery residency at Massachusetts General Hospital and surgical oncology fellowship at M.D. Anderson Cancer Center. \nDr. Raut currently serves as Chair of the AJCC Soft Tissue Sarcoma Staging Panel (9th edition)\, Co-Chair of the Surgery Committee in the cancer cooperative group Alliance for Clinical Trials in Oncology\, and Treasurer on the Executive Board of the Connective Tissue Oncology Society.  In 2013\, he co-founded the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.  He is the former Program Director of the Mass General Brigham/Dana-Farber Complex General Surgical Oncology Fellowship Program at Harvard Medical School.  He serves as Section Editor for sarcoma in the journals Cancer and Surgical Oncology Insights.  He has authored over 300 papers and over 30 book chapters. \n \nDr. Hop Tran Cao\nMD Anderson Cancer Center \nDr. Hop Tran Cao is an Associate Professor and Vice-Chair of Clinical Operations in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center\, where he specializes in the management of hepatobiliary tumors. He is an expert in minimally invasive surgical techniques and chairs the Minimally Invasive and New Technology in Oncologic Surgery governing committee at MD Anderson. He also chairs the multidisciplinary Histotripsy Steering Committee. \nDr. Tran Cao’s research focuses on improving cancer care quality and precision. He completed his General Surgery residency at the University of California San Diego and his fellowship in Complex General Surgical Oncology at MD Anderson. \n \nDr. Jiping Wang\nBrigham and Women’s Hospital \nDr. Jiping Wang is a surgical oncologist at Brigham and Women’s Hospital. He specializes in treating gastric\, liver\, and pancreatic cancer and soft tissue sarcoma. He has a special interest in using minimally invasive platforms to perform cancer surgeries. In this video he explains robotic surgery for patients.
URL:https://liferaftgroup.org/event/histotripsy-demystified/
CATEGORIES:Education,Events
ORGANIZER;CN="Rebecca Pauley":MAILTO:rpauley@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260321T080000
DTEND;TZID=America/New_York:20260321T160000
DTSTAMP:20260406T165019
CREATED:20260210T162611Z
LAST-MODIFIED:20260320T152459Z
UID:10001161-1774080000-1774108800@liferaftgroup.org
SUMMARY:GIST Summit 2026 / GDOL Texas
DESCRIPTION:REGISTERMD Anderson Cancer Center\, GIST Support International and The Life Raft Group are hosting a GIST Summit / GDOL Texas 2026 for  GIST patients and caregivers in Houston\, Texas in March 21 to showcase recent developments in GIST treatments and therapies. \n\n \n\n \nThis free event is being sponsored through educational and other grants and gifts from pharmaceutical companies and individual donors. The program will include numerous presentations on the current state of GIST as well as future treatments and one-on-one conversations with the experts. All meals\, refreshments\, and parking will be provided. \nPlease join our community of GIST patients and caregivers for these relevant and informative talks\, meet with old friends and new\, and catch up on the latest science. Previous GIST Summits and GIST Days of Learning have been great successes\, and this year’s program is exciting as ever. Where else can you discuss GIST issues with the experts and ask questions you always wanted to ask? You will also have time to meet with other GIST patients and caregivers and to share experiences. \nHave questions? Contact Brian Morello: bmorello@liferaftgroup.org \nClick to view Agenda PDF \n\n \n\n \nThank You To Our Sponsors:
URL:https://liferaftgroup.org/event/gist-summit-2026-gdol-texas/
LOCATION:MD Anderson Cancer Prevention Center\, 1155 Pressler Street 8th Floor\, Houston\, TX\, 77030\, United States
CATEGORIES:Education,Events
ORGANIZER;CN="Brian Morello":MAILTO:bmorello@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260413T120000
DTEND;TZID=America/New_York:20260413T120000
DTSTAMP:20260406T165019
CREATED:20260324T133307Z
LAST-MODIFIED:20260325T130245Z
UID:10001637-1776081600-1776081600@liferaftgroup.org
SUMMARY:Long-Term Survivor Webinar
DESCRIPTION:REGISTERHosted by the The Life Raft Group\, “What We Wish We’d Known: Advice from Long-Term GIST Survivors” will take place on April 13 at 12 PM ET and features long-term survivors and mentors Kay Stolzer\, Dr. John Abrams\, Martha Smart\, and Piga Fernández. They’ll share what to do after a GIST diagnosis\, common mistakes to avoid\, and what it’s really like to live with cancer long-term. Join us for practical advice\, honest insights\, and support from people who have been there. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. \nAbout Our Presenters:\n \nDr. John Abrams \nJohn Abrams has been involved with The Life Raft Group for over eight years and is the state leader for Colorado. He serves as a LRG Board Member and GIST mentor. He practiced dentistry for 35 years with an area of expertise in adult restorative dentistry highlighting esthetic restorations. He was honored by his peers as a Colorado 5280 Top Dentist. John retired from dentistry due to the side effects of Gleevec. In his “retirement” he is an equity partner in real estate investment and serves as a consultant for dental offices focusing on management and clinical skills. \nJohn grew up in St. Louis and has lived in Colorado since 1975. He graduated from Miami University (Oxford Ohio) and the University of Missouri School of Dentistry. \nAs a long time GISTer and survivor of two other primary cancers\, John hopes his story can be at least some inspiration to others on their own journey. \n \nPiga Fernández \nAs a GIST patient who was diagnosed incorrectly in 1995 with leiomyosarcoma\, Piga Fernández understands the importance of correct diagnosis and access to treatment. Piga serves as a GIST Mentor and Global Relations Consultant for The Life Raft Group. \nIn 2001\, she founded and is the Executive Director of Fundación GIST Chile\, a nonprofit organization dedicated to support GIST and other gastrointestinal patients through education\, information\, emotional support and advocacy\, with the goal of having them experience a better quality of life. \nAdditionally\, she is the Coordinator of Alianza GIST\, a consortium of GIST groups in Latin America. Her advocacy efforts in Chile have led to important changes in her country\, impacting both legislative change and raising awareness for rare diseases. \n \nMartha Smart \nMartha Smart is a 19-year survivor of high-risk small bowel GIST (12 cm\, Exon 11) and has been on Gleevec since her diagnosis in 2007. A former speech pathologist based in Midland\, Texas\, she is a proud mom\, grandmother (“NeeNee”)\, dog mom\, and devoted wife of over 53 years. \nHer diagnosis came as a complete shock following emergency surgery\, prompting her to take an active role in her care and seek treatment at MD Anderson. Since then\, she has taken more than 27\,000 Gleevec tablets and become deeply connected to the GIST community through The Life Raft Group and other networks. \nWith humor\, resilience\, and compassion\, she is passionate about sharing her experience to support and guide others living with GIST. \n \nKay Stolzer \nKay Stolzer joined the LRG Board in March 2021 and was elected to the role of Secretary/Treasurer in March 2022. \nShe has been a very active volunteer in our LRG community. Kay is one of the original 8 GIST Mentors\, a program that has grown to 32 global mentors\, and has mentored over 220 patients and caregivers\, since its inception in 2019. \nIn Kay’s earlier life\, she was an administrator for a large physicians’ group. When her children were born\, she transitioned to full time homemaker\, and was a very active volunteer in her community\, in various roles and organizations. Kay enjoys spending time with her husband\, Ira\, and visiting their children and grandchildren in New Jersey and Tennessee. \nThank You to Our Sponsors:
URL:https://liferaftgroup.org/event/long-term-survivor-webinar/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Rebecca Pauley":MAILTO:rpauley@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260601
DTEND;VALUE=DATE:20260602
DTSTAMP:20260406T165019
CREATED:20260325T150949Z
LAST-MODIFIED:20260325T151018Z
UID:10001639-1780272000-1780358399@liferaftgroup.org
SUMMARY:National Cancer Survivors Day
DESCRIPTION:June 1st is National Cancer Survivors Day.
URL:https://liferaftgroup.org/event/national-cancer-survivors-day/
CATEGORIES:Education,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260710T150000
DTEND;TZID=America/New_York:20260712T120000
DTSTAMP:20260406T165019
CREATED:20250617T191752Z
LAST-MODIFIED:20260403T201037Z
UID:10000827-1783695600-1783857600@liferaftgroup.org
SUMMARY:Life Fest 2026 - Nashville
DESCRIPTION:Life Fest 2026 will be in Nashville\, Tennessee – Friday\, July 10th through\, Sunday July 12th\, 2026 at the Loews Vanderbilt Hotel\, 2100 West End Avenue\, Nashville\, TN. Hotel\, airline & parking information is on the registration page. \nScholarships are available! Please submit your request through this form.\nIf you would like to donate to the scholarship fund\, visit this link. \n\nREGISTERDownload PDF of Agenda (subject to change.) \n\n \n\n \n\n \n\n \n\n \n\nWe have secured a block of hotel rooms for guests attending Life Fest 2026. This special group rate is only available until June 19th\, 2026. \nLoews Nashville Hotel at Vanderbilt Plaza\n2100 West End Ave\,\nNashville\, TN 37203\n1-877-879-7818 \nReserve: www.loewshotels.com/vanderbilt-hotel/group-life-fest-event-2026 \nParking for the conference location (Loews Nashville Hotel at Vanderbilt Plaza):\nSelf-parking for guests at Loews Nashville Hotel at Vanderbilt Plaza is $49 + tax per day\, per vehicle. \nAlternate parking:\nLegacy Parking Company\, LLC – Hayes Street Garage (4 minute walk to Loews Hotel)\n2011 Hayes St\, Nashville\, TN 37203\n1-209-489-7232 \nFor parking details: bit.ly/LF-BookParking \nQuestions about Life Fest 2026?\nPlease reach out to Brian Morello\, Director of Development at bmorello@liferaftgroup.org \nThank You To Our Sponsors:
URL:https://liferaftgroup.org/event/life-fest-2026-nashville/
LOCATION:Loews Vanderbilt Hotel\, 2100 West End Avenue\, Nashville\, TN\, 37203\, United States
CATEGORIES:Education,Events
ORGANIZER;CN="Brian Morello":MAILTO:bmorello@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260713
DTEND;VALUE=DATE:20260714
DTSTAMP:20260406T165019
CREATED:20260325T131420Z
LAST-MODIFIED:20260325T131657Z
UID:10001638-1783900800-1783987199@liferaftgroup.org
SUMMARY:GIST Awareness Day
DESCRIPTION:GIST Awareness Day is July 13th.
URL:https://liferaftgroup.org/event/gist-awareness-day/
CATEGORIES:Education,Events
END:VEVENT
END:VCALENDAR